RFP
EDIT icon

Root Financial Partners’s Editas Medicine EDIT Stock Holding History

Root Financial Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-503
Closed -$1.24K – 1197
2026
Q1 		$1.24K Buy
+503
New +$1.06K ﹤0.01% 2519
2025
Q4 		– Sell
-100
Closed -$347 – 2459
2025
Q3 		$347 Buy
+100
New +$279 ﹤0.01% 2172

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Root Financial Partners's EDIT Position: Q2 2026 in Review

Root Financial Partners sold out of Editas Medicine (EDIT) in Q2 2026, closing a stake of 503 shares — an estimated $1.24K sold.

Root Financial Partners first reported a position in EDIT in Q3 2025 and held it in 2 quarters. The position peaked at $1.24K in Q1 2026. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Root Financial Partners reported no remaining Editas Medicine position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 503 Editas Medicine shares in Q2 2026, an estimated $1.24K.
  • Root Financial Partners first reported a position in Editas Medicine in Q3 2025 and held it in 2 quarters.
  • Root Financial Partners's Editas Medicine position peaked at $1.24K in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.